Despite the outbreak of multidrug-resistant bacterial infections linked to duodenoscopes, healthcare providers should not cancel endoscopic retrograde cholangiopancreatography (ERCP) procedures for ...

Endoscopists and centers that performed a high volume of endoscopic retrograde cholangiopancreatography procedures showed higher rates of overall procedural success and lower rates of adverse events ...

New York, June 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Endoscopic Retrograde Cholangiopancreatography/ERCP Market Size, Share & Industry Trends ...

Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard diagnostic tool to detect common bile duct (CBD) stones; however, endoscopic ultrasound (EUS) is less invasive than ERCP and ...

The endoscopic retrograde cholangiopancreatography (ERCP) devices market sales is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence ...

Endoscopic retrograde cholangiopancreatography (ERCP) is a medical technique that is used primarily to investigate and treat pathologies involving the biliary tree and pancreatic ducts. Image Credit: ...

Endoscopy procedures dominate the practice of most gastroenterologists in U.S. The common types, upper endoscopy and colonoscopy, are mostly performed in ambulatory care centers and offices. ERCP ...

Dec. 18, 2003 — A single dose of intravenous bolus somatostatin given immediately after diagnostic endoscopic retrograde cholangiopancreatography (ERCP) is effective in reducing the incidence of ...